Navigation Links
Strategic Alliance Formed to Fight Counterfeit Drugs
Date:10/29/2013

WASHINGTON, Oct. 29, 2013 /PRNewswire-USNewswire/ -- A new partnership to improve access to high quality, safe and beneficial medicines was formalized today between the Global Pharma Health Fund (GPHF), a charitable organization initiated and funded exclusively by donations from Merck KGaA, Darmstadt, Germany, and the Center for Pharmaceutical Advancement and Training (CePAT) in Ghana, a facility established by the U.S. Pharmacopeial Convention (USP) to help build local and regional capacity in pharmaceutical quality assurance and quality control.

"CePAT is one of the most important initiatives to ever be implemented in this part of the world, as it goes deep into the root problem of lack of quality medicines in Africa, which is insufficient human resource capacity," said Dr. Stephen K. Opuni, CEO of the Ghana Food and Drugs Authority.

"We at GPHF are excited about this opportunity to partner with CePAT on this important initiative to combat the scourge of counterfeit drugs. Substandard and fake medicines pose a true public health threat," said Frank Gotthardt, Chairman of the Global Pharma Health Fund.

Counterfeit medications are a major challenge in developing countries, where there are limited resources for screening and quality assurance.

The collaboration between CePAT and GPHF outlines a strong plan to improve local capacity to detect substandard and counterfeit drugs through training at CePAT's facility in Ghana and the use of the GPHF-Minilab®, a mobile mini-laboratory for rapid drug quality verification and counterfeit medicines detection.

Both the GPHF and CePAT believe that this strengthened cooperation will contribute to realizing their common vision, which is of a world in which all citizens have access to high quality, safe and beneficial medicines.

A memorandum of understanding formalizing the alliance will be signed today during a ceremony hosted by the H.E. Peter Ammon, the German Ambassador to the United States, at his residence in Washington, DC. 

About the Global Pharma Health Fund (GPHF)
The Global Pharma Health Fund (GPHF) is a charitable organization initiated and funded exclusively by donations from Merck KGaA, Darmstadt, Germany. Within international development assistance initiatives, GPHF aims to improve health care and medicines supply, the work currently supporting the fight against counterfeit and substandard quality medicines proliferation using GPHF-Minilab® test kits. The GPHF-Minilab® is a mobile mini-laboratory that helps in the detection of counterfeit medicines. It enables health facilities responsible for drug purchase, storage and distribution to protect themselves and patients against the danger of counterfeit medicines consumption. To date, 600 Minilabs have been supplied to health facilities across 80 countries. For more information, visit www.gphf.org.

About the Center for Pharmaceutical Advancement and Training (CePAT)
The Center for Pharmaceutical Advancement and Training (CePAT) in Accra, Ghana, was established by the U.S. Pharmacopeial Convention (USP) to help build human resource capacity in pharmaceutical quality assurance and quality control by training local professionals to serve as technical experts. Provided under USP's Global Health Impact Programs (GHIP), CePAT delivers an integrated platform of training, laboratory services and consulting services to support and strengthen quality assurance systems in a sustainable way in countries in Sub-Saharan Africa. For more information visit: http://uspgo.to/CePAT-program.


'/>"/>
SOURCE Global Pharma Health Fund
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
2. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
3. Herborium Announces Continuing Progress In Key Strategic Initiatives
4. Amendia, Inc. and Medline Industries, Inc. Announce Investment and Strategic Business Alliance
5. UBM Canon, the Global MedTech Authority, Announces Strategic Alliance with ITG Market Research, a Preeminent Industry Research Organization
6. Watson to Present at the Sanford C. Bernstein 28th Annual Strategic Decisions Conference
7. VitaTech Adds New Capacity for Production and Customer Interface, Attributes Growth to Strategic Customer Partnerships
8. Elekta and The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital Sign Strategic Alliance to Further Cancer Research
9. Lilly Expands Strategic Partnership with Chinese Manufacturer Novast to Serve Chinese Patients with High-Quality Branded Generic Medicines
10. Medifast Announces International Expansion Into Mexico Through Strategic Partnership with Medix
11. Dehaier Medical Announces Strategic Mutual Cooperation Agreement with HEYER Medical AG
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... BASEL, Switzerland and SAN DIEGO ... Houston , Inc., a global leader in viral gene ... gene therapy treatments for congestive heart failure and other ... to develop a scalable manufacturing process and produce cGMP-grade ... clinical trials. --> ...
(Date:2/10/2016)... Immune Pharmaceuticals Inc. (NASDAQ: IMNP ), ... has filed a patent application directed to the treatment ... --> --> The new invention ... (histamine dihydrochloride) in combination with immune checkpoint inhibitors. The ... of Ceplene and IL-2 therapy in patients with Acute ...
(Date:2/10/2016)... ANGELES , Feb. 10, 2016  Oxis International ... cancer drug, OXS-1550, was described as a "clinical trial ... the drug went into complete cancer remission. ... University of Minnesota Masonic Cancer Center. --> ... University of Minnesota Masonic Cancer Center. --> ...
Breaking Medicine Technology:
(Date:2/10/2016)... IN (PRWEB) , ... February 10, 2016 , ... ... benefits advisory organization, welcomes S.S. Nesbitt as the latest addition to its growing ... has seven other locations throughout the Southeast, from Orlando to Huntsville and in ...
(Date:2/10/2016)... ... ... Armune BioScience signed a definitive agreement with ARCpoint Labs ... the country. Launched in April of 2015, Apifiny is the only cancer specific, non-PSA ... volume exceeded 3,000 tests in 2015. Primary care physicians and urologists have utilized Apifiny ...
(Date:2/10/2016)... ... February 10, 2016 , ... For additional information contact ... , Pioneering book "Better with Age: The Ultimate Guide to Brain Training" by award-winning ... improve memory. The book’s publication date is March 16, 2016. A free review ...
(Date:2/10/2016)... ... February 10, 2016 , ... Everseat has joined the award-winning ... to physicians. The integration will enable Allscripts users to post open appointments to ... mobile app. , The partnership gives Everseat substantial added power to help Allscripts ...
(Date:2/10/2016)... ... ... Workrite Ergonomics this week announced the launch of the Conform Monitor Arm Series, ... was to develop a product from the ground up that would provide the most ... Hulsey, Product Manager for Workrite Ergonomics. “The Conform series features a wide variety ...
Breaking Medicine News(10 mins):